[ALA] QoQ Quarter Result on 31-Dec-2021 [#Q2]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Dec-2021
Financial Year
2022
Quarter
31-Dec-2021 [#Q2]
Profit Trend
QoQ- -100.00%
YoY- -126.10%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 714 273 137 23 11 15 319 71.02%
PBT -1,950 -4,671 -2,335 -3,950 -1,975 -3,923 -1,650 11.76%
Tax 0 -0 0 -0 0 -623 0 -
NP -1,950 -4,671 -2,335 -3,950 -1,975 -3,300 -1,650 11.76%
Tax Rate - - - - - - - -
Total Cost 2,664 4,944 2,472 3,973 1,986 3,315 1,969 22.30%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -272.98 -1,709.47 -1,709.48 -17,484.78 -17,484.01 -22,288.88 -517.19 -34.66%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -
EPS Diluted -0.00 -0.01 -0.00 -0.01 -0.00 -0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.